NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR

Thursday 29 January 2009

Excelsyn reports strong sales; strengthens capabilities

Excelsyn's sales in its H1 2008/2009 were $10.98m. President and CEO Ian Shott said that progress has continued in the third quarted and it is "on track to more than double our EBITDA for FY 2008-09 – moving up to 16% from the 7% delivered in FY 2007/08".
Excelsyn has recently strengthened its capabilities at the Holywell, North Wales facility with the addition calorimetry equipment and a laboratory hydrogenation capability. The company has also completed the initial phase of its three-year expansion and upgrade programme at Holywell.
Excelsyn

No comments: